Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00352391 · ClinicalTrials.gov registry record
Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 54
- Enrollment target
NCT00352391: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00352391 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00352391 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The goal of this research study is to look at how long individuals who have been treated for early stage NSCLC or HNSCC live without developing lung cancer. Another goal is to develop tools to help predict the likelihood of lung cancer occurrence in this population. This will be done by studying characteristics of tissue and bodily fluids (including blood). Objectives: * To assess the smoking-related disease-free survival in patients who are current or former smokers with a prior definitively-treated stage I/II lung or head and neck cancer. * To develop a risk model to help predict the likelihood of lung cancer development both imaging and biomarker based in this high-risk population.
Primary Outcome
Smoking-related disease-free survival (S-DFS) defined as time from registration to the development of recurrence, smoking related SPT, or disease-specific death, whichever occurs first.
Interventions
- OTHER Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2004-08 |
| Est. Completion | 2016-01 |
What the finished NCT00352391 record still lists
NCT00352391 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Assessments is the first listed.
NCT00352391 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00352391 about?
NCT00352391 is a clinical study titled "Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients". The goal of this research study is to look at how long individuals who have been treated for early stage NSCLC or HNSCC live without developing lung cancer. Another goal is to develop tools to help predict the likelihood of lung cancer occurrence in this population. This will be done by studying cha...
What is the current status of trial NCT00352391?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2004-08. Estimated completion is 2016-01.
What interventions are being tested in trial NCT00352391?
The interventions under investigation include: Assessments (OTHER).
Who is sponsoring clinical trial NCT00352391?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia